Author: admin

A long-running dispute between OKX founder Star Xu and Binance founder Changpeng “CZ” Zhao resurfaced Thursday, with Xu calling CZ a “habitual liar” in a series of posts on X that revisit allegations dating back more than a decade.The clash traces back to Zhao’s brief tenure at OKCoin, founded by Xu, when he was accused in 2015 of “harmful acts of conduct” and misleading statements tied to a contract dispute involving Roger Ver, claims Zhao has previously disputed.This latest flare-up also follows an earlier public disagreement in January, when Xu blamed Binance-linked market dynamics for amplifying the Oct. 10 crypto…

Read More

AlphaTON Capital Corp. (NASDAQ: ATON) (“AlphaTON”), today released GAMEE’s unaudited Q1 2026 performance update.The GAMEE acquisition completion is on target for an April close. During this time, GAMEE has demonstrated the potent synergy between hyper-casual gaming and the Telegram ecosystem. Q1 2026 Financial & Operational Highlights GAMEE entered 2026 with significant momentum, posting an estimated $926,000 in revenue for the first quarter. This represents a 56% Year-over-Year (YoY) growth compared to Q1 2025 ($593,000), driven by a robust portfolio that attracted over 5.57 million users and 88.5 million gameplays in just three months. Current Reach: 1.7M MAUs and 150k DAUs across all platforms. Expansion: Increased footprint within the Telegram Mini App…

Read More

Prediction markets are seeing steady growth in the U.S., but a wave of legal disputes and shifting competition is beginning to reshape the sector, a new report from Bank of America said.Total weekly volume rose 4% week-over-week, according to the report, with Kalshi — a federally regulated exchange — leading gains at 6%. Crypto.com posted a smaller increase, while Polymarket, a crypto-native platform that had surged in prior weeks, saw overall volumes fall 16%.Kalshi now controls roughly 89% of measured U.S. prediction market volume, far ahead of Polymarket at 7% and Crypto.com at 4%, according to BofA estimates. The shift…

Read More

Raymond James upgraded Instacart (CART) to Outperform with a $50 price target, citing accelerating platform growth, expanding EBITDA margins to 31%, and high-profile enterprise wins like ALDI that embed the company deeper into retailer infrastructure. Instacart’s valuation at 16x forward P/E trades at a substantial discount to comparable peers, while the company’s diversified revenue streams—including a newly billion-dollar advertising business and growing SaaS enterprise platform—position it for a re-rating. The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE. Instacart (NASDAQ:CART), also known as Maplebear, got a meaningful vote of confidence Thursday…

Read More

In the fast-evolving financial landscape of 2026, manual chart monitoring is rapidly becoming a relic of the past. Today, AccuQuant, a global leader in quantitative technology, officially unveiled its flagship product: the Next-Gen AI Trading Bot. This launch is more than just a product update—it is a gateway for retail investors to enter the era of “Institutional-Grade Algorithms.”     Why is AccuQuant Hailed as the “Most Advanced AI Trading Bot of 2026”? When users search for the “Best AI Trading Bot” on Google, their primary concerns are speed, security, and ease of use. AccuQuant addresses these pain points through three…

Read More

Bitcoin BTC$71,173.86 has pulled above $70,000 on news of the Iran ceasefire, but the rally is, for now, fairly cautious.There may be good reasons for that.One of the more reliable signals for gauging where bitcoin may be headed comes from tracking margin long positions on Bitfinex. These positions, which reflect bullish bets funded with borrowed capital, still remain elevated at 80,057 BTC, around the highest level in more than two years, according to TradingView data. The data suggests these long positions are not being unwound despite the price being more than 15% higher since bottoming at $60,000 two months ago.…

Read More

“In the short time since early and full approval, the standard-of-care first-line treatment is seeing tremendous progress,” said Precigen’s (PGEN) President and CEO, Helen Sabzevari, during a conference call to discuss fourth quarter results. “This substantial advancement constitutes a pivotal milestone for all stakeholders impacted by RRP.” As a result of the interest in PAPZIMEOS, Sabzevari said the company is transforming from a research and development biopharmaceutical company to a product revenue generating biotech company. Net product sales of PAPZIMEOS were $3.4M in the fourth quarter of 2025, with shipments commencing in November. In the fourth quarter, Precigen patient hub…

Read More